Navigation Links
Ibrutinib Receives Two Oncology Breakthrough Therapy Designations from U.S. Food and Drug Administration
Date:2/12/2013

e Private Securities Litigation Reform Act of 1995. The reader is cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Janssen Research & Development, LLC, any of the other Janssen Pharmaceutical Companies and/or Johnson & Johnson. Risks and uncertainties include, but are not limited to, general industry conditions and competition; economic factors, such as interest rate and currency exchange rate fluctuations; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; challenges to patents; changes in behavior and spending patterns or financial distress of purchasers of healthcare products and services; changes to governmental laws and regulations and domestic and foreign health care reforms; trends toward health care cost containment; and increased scrutiny of the healthcare industry by government agencies. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended January 1, 2012. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.govwww.jnj.com or on request from Johnson & Johnson. None of the Janssen Pharmaceutical Companies nor Johnson & Johnson undertake to update any forward-looking statements as a result of new information or future events or developments).                            
'/>"/>

SOURCE Janssen Research & Development, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, in Relapsed/Refractory Mantle Cell Lymphoma Presented at American Society of Hematology Annual Meeting
2. Follow-up Results of Phase 2 Study of Investigational Agent, Ibrutinib, Suggest High and Durable Responses in Relapsed/Refractory Mantle Cell Lymphoma
3. Pharmacyclics Announces Oral Presentations of Ibrutinib (PCI-32765) at the 17th Congress of the European Hematology Association
4. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
5. Remique (TM), a Revolutionary Dietary Supplement, Manufactured in FDA Registered Facilities, Receives Raves from Compromised Immune System Sufferers
6. Life Technologies Receives FDA 510(k) Clearance for Diagnostic Use of Sanger Sequencing Platform and HLA Typing Kits
7. Rafarma Pharmaceuticals, Inc. Receives General License for Pharmaceutical Products and has Started to Manufacture 3 New Products
8. Morphotek Inc. Pilot Plant Receives 2013 Facility of the Year Award
9. Arteriocyte Receives FDA Approval to Initiate Cellular Therapy Trial for Treatment of Thermal Burn Wounds in Wounded Warriors
10. Virtual Ports Receives Patent Approvals in the United States and Japan
11. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
(Date:8/21/2014)... Germany , Aug. 21, 2014  IBM (NYSE: ... Elektronen-Synchrotron ( DESY ), a leading national research center ... management and storage of massive volumes of x-ray data. ... based on IBM software defined technology can handle more ... performance and help scientists worldwide gain faster insights into ...
(Date:8/21/2014)...  Seventy-one percent of Americans believe the abuse of strong ... health and safety issue in the United States ... by Repass & Partners, a Cincinnati ... severity of the prescription medication abuse problem and the need ... health situation facing our country," Rex Repass , CEO ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3DESY and IBM Develop Big Data Architecture for Science 2DESY and IBM Develop Big Data Architecture for Science 3Consumers Desperate For Measures To Curb Prescription Drug Abuse 2Consumers Desperate For Measures To Curb Prescription Drug Abuse 3
... Fla., Dec. 5, 2011 Hybrid Fuels, Inc., (Pink ... of its main business activities and new strategic goals.  ... a nutraceutical/pharmaceutical business venture that will focus on providing ... normally be treated or addressed with pharmaceutical drugs that ...
... Pharmaceuticals, Inc. (Nasdaq: ANTH ), a biopharmaceutical ... inflammation and autoimmune disorders, today announced Dr. Debra Odink ... Officer and Senior Vice President. "Over ... scientific leadership has been critical to the success of ...
Cached Medicine Technology:Hybrid Fuels, Inc. Announces New Business Strategy 2Anthera Pharmaceuticals Promotes Dr. Debra Odink to Chief Technology Officer 2
(Date:8/22/2014)... UT (PRWEB) August 22, 2014 Today, ... a new guide on Account-Based Health Plans. , According ... (ABHPs) as a strategy to lower the cost of ... types of medical spending accounts, however, can be confusing. ... chart to learn the four main types of ABHPs. ...
(Date:8/22/2014)... MyWriters.com , an online source ... experts for marketers to help them drive traffic to ... of Shane Michaels, prompting an investigative review. , ... way knows that content is king when it comes ... “But even though content is extremely important, creating quality, ...
(Date:8/22/2014)... 22, 2014 Buying a policy for different ... is unsure about available coverage types by insurers in the ... insurance policy pricing to the public using its sortable tool ... tool is free and is expected to promote the discounts ... public throughout the U.S. The system is designed to help ...
(Date:8/22/2014)... FL (PRWEB) August 22, 2014 Millennium Treatment ... marijuana, resulting in a high level of drug use among ... ages fight against drug addiction and work to minimize drug ... levels of alcohol and drug addiction in history. According to ... an estimated 23.9 million Americans aged 12 or older—or 9.2 ...
(Date:8/22/2014)... Amy Norton HealthDay Reporter ... A growing number of Americans on work disability chronically ... Researchers found that between 2007 and 2011, about ... benefits were prescribed narcotic painkillers each year. And the ... in 2007 to 23 percent in 2011. ...
Breaking Medicine News(10 mins):Health News:My Writers: Review Exposes Online Source for Quality Marketing Content 2Health News:Principal Life Insurance Policies Now Quoted for Adults at Insurance Website Online 2Health News:Millennium Treatment Group Sees Increase in Marijuana Use Among Youth 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4
... both conditions, study finds , , MONDAY, June 30 (HealthDay ... development of high blood pressure, diabetes and immune problems, researchers ... the body, clipping off working segments of the receptors that ... to a report in the June 30 online issue of ...
... care organizations , ... ROUND ROCK, Texas (Business Wire ... today operate under the mantra that ,more is better, when it ... Health Care and Life Sciences. "Virtualizing the IT infrastructure fully illustrates ...
... Convene in Chicago, August 2-3, CHICAGO, June ... everything,in between, dermatology nurses and related professionals play ... their patients., The Dermatology Nurses, Association (DNA) ... variety of learning formats and,the profession,s best networking ...
... The American Heart,Association has set August for the ... of six new titles to be published,under the banner ... will be published by Lippincott Williams & Wilkins, a ... has been named editor of the new journal. Faxon,is ...
... support surface products to be included as part of company,s, ... ... preventing pressure ulcers, MUNDELEIN, Ill., June 30 ... pressure redistribution,mattresses, operating room table pads and stretcher pads aimed ...
... the development, marketing and sale of proprietary, patent-pending nutraceutical products, including ... is launching a new pet health care division. , ... ... -- The pet health care division is designed to expand ...
Cached Medicine News:Health News:New Molecular Trigger Described for Hypertension, Diabetes 2Health News:New Molecular Trigger Described for Hypertension, Diabetes 3Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 2Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 3Health News: Virtualization with Dell Helps Cure Growing Health Care IT Ills 4Health News:4th Annual Dermatology Nurses' Association Summer Meeting to Arrive in Windy City 2Health News:American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August 2Health News:American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August 3Health News:American Heart Association Announces Fourth New Journal - Circulation: Cardiovascular Interventions to Debut in August 4Health News:Medline Announces Advanced Line of Therapeutic Mattresses, Operating Room Table Pads and Stretcher Pads 2Health News:Medline Announces Advanced Line of Therapeutic Mattresses, Operating Room Table Pads and Stretcher Pads 3Health News: University Health Industries Launches Natural Pet Health Care Division 2
The rectangular large-field lens of the 2631 are ideal for reading and writing....
The Multi-Purpose Stand Magnifier is the most versatile stand magnifier. The stand has multiple configurations allowing for all situations where hands-free magnification is needed....
Thinprofile design eyelid implants....
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Medicine Products: